Do try not to be misleading in your analysis. You may have heard of sample size amongst your trolling. n=1 doesn't really past muster Pledge. Thought you'd have worked that out by now. Do be thorough and tell us all of the ones discussed (this not even recent):
"Most recently, IQVIA released a report finding that 25 of 59 (42%) novel drugs approved in 2018 were approved on the basis of only one trial. And one out of eight approvals relied only on Phase 1 or 2 trials, with no Phase 3 trials. But as in previous years, a large portion of the drugs relying on only one trial were new orphan and cancer drugs."
https://www.raps.org/News-and-Articles/News-Articles/2019/5/Almost-Half-of-All-New-Drug-Approvals-in-2018-Reli
Your actual one example OF MANY actually even refutes your very statement above of none reaching commercialisation:
"the company will remove the drug from market".
Ergo it was in the market. You can't even read your own reports properly that prove exactly your earlier statement as incorrect.
So yeah, "next".
- Forums
- ASX - By Stock
- Ann: First USA site initiated in aGvHD trial
CYP
cynata therapeutics limited
Add to My Watchlist
0.00%
!
16.5¢

Do try not to be misleading in your analysis. You may have heard...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
16.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.28M |
Open | High | Low | Value | Volume |
17.0¢ | 17.0¢ | 16.0¢ | $29.18K | 176.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 66467 | 16.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.5¢ | 65000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 66467 | 0.160 |
4 | 181490 | 0.155 |
5 | 318045 | 0.150 |
4 | 81775 | 0.145 |
4 | 307863 | 0.140 |
Price($) | Vol. | No. |
---|---|---|
0.175 | 65000 | 1 |
0.185 | 35419 | 2 |
0.190 | 114978 | 3 |
0.195 | 5764 | 1 |
0.200 | 55400 | 2 |
Last trade - 15.59pm 25/07/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online